Followers | 493 |
Posts | 30537 |
Boards Moderated | 3 |
Alias Born | 01/31/2008 |
Tuesday, May 23, 2023 5:51:07 PM
All posts are my opinion and are not recommendations to buy or sell
Recent CELU News
- Celularity Inc. to Host Investor and Analyst Research & Development Day • GlobeNewswire Inc. • 04/22/2024 12:00:00 PM
- Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing • GlobeNewswire Inc. • 04/19/2024 09:30:00 PM
- Celularity Abstract “Emerging Technologies for the Management and Protection of Tendon Injuries: Decellularized Placental Biomaterials” Accepted at ORS Tendon Conference 2024 • GlobeNewswire Inc. • 04/18/2024 08:30:00 PM
- Celularity Announces Net Sales Trending Ahead of Expectations for First Quarter 2024; Implements Planned 2024 SG&A Reductions and Manufacturing Ramp for Advanced Biomaterial Products • GlobeNewswire Inc. • 04/15/2024 12:00:00 PM
- Celularity to Present Data Showing Senescent Cell Elimination by Off-the-Shelf Natural Killer Cells Derived from Human Placental Cells • GlobeNewswire Inc. • 04/08/2024 01:00:00 PM
- Celularity Receives Healthcare Common Procedure Coding System (HCPCS) Q Code Approval from the U.S. Centers for Medicare & Medicaid Services for Biovance® 3L • GlobeNewswire Inc. • 03/26/2024 01:00:00 PM
- Celularity Submits Request to U.S. FDA for Orphan Drug Designation for PDA-002 Asset Treating Facioscapulohumeral Muscular Dystrophy • GlobeNewswire Inc. • 03/20/2024 01:15:00 PM
- Celularity CEO to Present on Cell Therapy’s Potential to Improve Longevity at 2024 ABUNDANCE Summit • GlobeNewswire Inc. • 03/14/2024 01:15:00 PM
- Celularity CEO to Present Keynote Address at 2024 Society for Brain Mapping and Therapeutics Annual World Congress • GlobeNewswire Inc. • 03/12/2024 01:20:51 PM
- Celularity to Present Data Showing Cancer Tumor Reduction by Off-the-Shelf Cell Therapy Derived from Human Placental Cells • GlobeNewswire Inc. • 03/07/2024 02:35:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 10:15:23 PM
- Celularity Announces 1-for-10 Reverse Stock Split • GlobeNewswire Inc. • 02/23/2024 09:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 02:05:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 02:38:15 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 02:22:50 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 02:18:32 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 02:14:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 02:10:27 AM
- Celularity’s Tri-layer Decellularized, Dehydrated Human Amniotic Membrane Product Investigated as a Carrier of Induced Pluripotent Stem Cell Derived-Limbal Stem Cells in the Treatment of Severe Ocular Surface Disease • GlobeNewswire Inc. • 02/14/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 09:15:28 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 02/02/2024 11:01:30 AM
- Celularity Announces Net Sales Expectations for First Quarter 2024 and Full Year 2024, Reiterates Advanced Biomaterial Product Commercial and Development Pipeline • GlobeNewswire Inc. • 02/01/2024 02:00:00 PM
- Celularity and Genting Leaders Comments on Closing $21 Million Financing Transactions • GlobeNewswire Inc. • 01/25/2024 02:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 01/23/2024 11:02:00 AM
- Celularity Releases CEO Letter to Shareholders • GlobeNewswire Inc. • 01/18/2024 06:40:38 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM